GGB is committed to providing updated news and analysis on our weekly news site, GGBNews.com.

Gronau Steps Down at GPI

Gronau Steps Down at GPI

Table-game supplier Gaming Partners International announced that Gregory Gronau is resigning as CEO of the company effective September 21, at which time he also will relinquish his other roles with the company, including president, director, treasurer and secretary. According to the company’s announcement, the resignation was “for personal reasons, and not a result of any disagreement with the company or its management.”

Alan Thieffry, the company’s chief financial officer and board chairman, will fill the CEO and other roles while the company searches for a successor.

Gronau, 59, has been CEO of the company since 2009, and was appointed secretary and treasurer in 2014. Prior to joining GPI, he was vice president of operations of Shuffle Master from 2002 to 2006 and, subsequently, CEO and president of Cadillac Jack, Inc. from January 2006 to March 2008. While with Shuffle Master, he was responsible for improvements in all of the company’s manufacturing operations, and was director of virtually all of its acquisitions.

Gronau will remain as a consultant to the company until the end of the year.

    Recent Feature Articles

  • Your Friend, Everi

    The supplier’s quest to raise all tides and all boats.

  • Gambling on the Mediterranean

    There are more gaming options in the region than expected, but things are about to change with massive projects planned for Greece and the Emirates

  • Threat or Opportunity?

    Gaming in the metaverse will look different than today’s gaming, but will it add value to the existing gaming companies, attract more players and pass regulatory scrutiny?

  • A Force in Sports Betting

    The third annual Bet Bash was designed by founder Gadoon “Spanky” Kyrollos to make gamblers better at wagering on sports

  • Problem Gambling Treatments Gain Ground

    Problem gambling wasn’t classified as a psychiatric disorder until 1980, but treatments are evolving and becoming more effective